Vasileios Zapridis

Dr. Vasileios Zapridis

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2025 in Veterinary Anaesthesia and Analgesia
Verified
Journal Article
Open access
ITILIANA TZORTZI
ILIANA TZORTZI
KVKonstantinos Varkoulis
Konstantinos Varkoulis
VZVasileios Zapridis
Vasileios Zapridis
GKGeorgios Kazakos
Georgios Kazakos
MPMichael Patsikas
Michael Patsikas
TATilemahos Anagnostou
Tilemahos Anagnostou
To evaluate the effect of quadratus lumborum block (QLB) on intra- and postoperative requirements for rescue analgesia (fentanyl) and on postoperative pain in dogs undergoing elective ovariohysterectomy. Randomized, blinded, placebo-controlled clinical trial. A group of 24 client-owned, healthy bitches scheduled for elective ovariohysterectomy. Dogs were assigned to receive either a QLB with 0.5 mL kg-1 per side bupivacaine 0.25% (BUP group) or an equivalent volume of NaCl 0.9% (SAL group). All dogs were anaesthetized using the same anaesthetic protocol. Intravenous fentanyl was intraoperatively administered whenever heart rate and/or respiratory rate and/or mean arterial blood pressure increased ≥ 20% from baseline following surgical stimulation. Postoperatively, pain was assessed blindly with the short form of the Glasgow Composite Measure Pain Scale (GCMPS-SF) and with measurement of para-incisional mechanical nociceptive thresholds (MNTs) at 20 minutes (t1), 1 (t2), 2 (t3), 4 (t4), 9 (t5) and 20 (t6) hours after extubation. Postoperative fentanyl/morphine were administered if the GCMPS-SF score exceeded 6/24; subsequent pain assessments were not performed. Chi-square test, Mann-Whitney U and general linear model for repeated measurements were used for statistical analysis; p < 0.05. Intraoperatively, four of 12 dogs and nine of 12 dogs received fentanyl in the BUP and SAL groups, respectively (p = 0.1). Total fentanyl consumption intraoperatively, was 1.5 μg kg-1versus 4.5 μg kg-1 in the BUP and SAL groups, respectively (p = 0.005). Postoperatively, one of 12 dogs in the BUP group received fentanyl compared with eight of 12 in the SAL group (p = 0.009). Significant differences (p < 0.005) were also observed in the GCMPS-SF scores and MNTs at all time points, with the BUP group having overall lower GCMPS-SF scores and higher MNTs. In this study, a QLB with bupivacaine, was an effective analgesic technique in dogs undergoing elective ovariohysterectomy, reducing opioid requirements and postoperative pain intensity.

28 June 2026 in Animals
Verified
Journal Article
Open access
PDF file
ESEirini Sarpekidou
Eirini Sarpekidou
MKMaria Koura
Maria Koura
KPKelly Pavlidou
Kelly Pavlidou
VZVasileios Zapridis
Vasileios Zapridis
Ioannis SavvasIoannis Savvas
Ioannis Savvas
GKGeorge Michel Kazakos
George Michel Kazakos
Background: The aim of the present retrospective observational study is to compare the required doses of propofol (PPF) for anaesthesia induction in dogs presented with intervertebral disc disease (IVDD)-related thoracolumbar or cervical myelopathy. Methods: The anaesthetic records of dogs with either cervical- or thoracolumbar-related myelopathy anaesthetised for diagnostic or surgical procedures from September 2021 to July 2023 were evaluated. Inclusion criteria were premedication with the same dose of dexmedetomidine (DEX) (180 μg m−2), and induction with PPF. The sedation score (SS), Glasgow Composite Measure Pain Scale-Short Form (GCMPS-SF) results and the total PPF dose required for intubation were collected. Data were analysed with the Shapiro–Wilk test, independent samples t-test and Spearman’s rho test. A value of p < 0.05 was considered statistically significant. Results: Fifty-five records were included in the study, 27 dogs with cervical and 28 with thoracolumbar myelopathy due to IVDD. Statistically significant higher doses of PPF were required in the dogs with cervical (mean 3.2 mg kg−1, ±SD 1.25 mg kg−1) than with thoracolumbar (mean 1.9 mg kg−1, ±SD 0.65 mg kg−1) myelopathy (t-test, p < 0.001). The SS in the dogs with cervical–cervicothoracic myelopathy (CCTM) (median 6, ±min 2 max 10) also differed from the SS of the dogs with thoracolumbar myelopathy (TLM) (median 7.5, min 2 max 12) (t-test, p = 0.02). Sedation score and the dose of PPF were significantly negatively correlated (Spearman’s rho −0.311, p = 0.021). Sedation score and GCMPS-SF were also significantly negatively correlated (Spearman’s rho −0.363, p = 0.007). However, no statistically significant negative correlation was found between PPF dose and GCMPS-SF score (Spearman’s rho = 0.248, p = 0.068). Conclusions: Our findings should be considered when planning anaesthetic protocols in patients suffering from IVVD-related myelopathy in order to optimize safety in these patients.